Hassan Javanbakht

Title: The Innovative Contributions of Hassan Javanbakht

Introduction

Hassan Javanbakht is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the treatment of viral disorders. With a total of 8 patents to his name, Javanbakht's work has the potential to impact the lives of many suffering from viral infections.

Latest Patents

Among his latest patents is an invention related to oligomers and oligomer conjugates. This invention focuses on an oligomer conjugate designed for the treatment of a viral disorder. The conjugate includes an oligomer that can modulate a target sequence in HBx and/or HBsAg of the Hepatitis B Virus (HBV). Additionally, it features a carrier component that delivers the oligomer to the liver, which is linked to the oligomer. Another significant patent involves nucleic acid molecules aimed at reducing PAPD5 or PAPD7 mRNA to treat hepatitis B infection. This method identifies compounds that can prevent or inhibit HBV infection by reducing the expression and activity of PAPD5 and PAPD7.

Career Highlights

Hassan Javanbakht has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of viral treatment.

Collaborations

Throughout his career, Javanbakht has collaborated with esteemed colleagues such as Søren Ottosen and Lykke Pedersen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hassan Javanbakht's contributions to biotechnology and his innovative patents demonstrate his commitment to improving treatments for viral disorders. His work continues to pave the way for advancements in medical science and offers hope for those affected by hepatitis B.